WallStreetZenWallStreetZen

NASDAQ: TERN
Terns Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TERN past revenue growth

How has TERN's revenue growth performed historically?
Company
-100%
Industry
112.01%
Market
13.97%
TERN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TERN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

TERN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$85.0M
Current Profit Margin
0%

TERN Return on Equity

Current Company
-31%
Current Industry
15.6%
Current Market
-9.5%
TERN's Return on Equity (-31%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TERN announces earnings.

TERN Return on Assets

Current Company
-29.6%
Current Industry
2.2%
TERN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TERN Return on Capital Employed

Current Company
-32.55%
Current Industry
17.7%
TERN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TERN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TERN$0.00-$83.61M-$85.01M-100.00%N/A
ALLO$186.00k-$319.07M-$332.86M-93.04%N/A
FUSN$2.21M-$83.36M-$91.34M+61.55%N/A
PROK$0.00-$30.80M-$36.25MN/AN/A
NRIX$68.61M-$135.78M-$148.71M+162.37%N/A
View Top Biotech Stocks

Terns Pharmaceuticals Earnings & Revenue FAQ

What were TERN's earnings last quarter?

On Invalid Date, Terns Pharmaceuticals (NASDAQ: TERN) reported Q3 2023 earnings per share (EPS) of -$0.42, up 4.55% year over year. Total Terns Pharmaceuticals earnings for the quarter were -$29.77 million. In the same quarter last year, Terns Pharmaceuticals's earnings per share (EPS) was -$0.44.

If you're new to stock investing, here's how to buy Terns Pharmaceuticals stock.

What was TERN's earnings growth in the past year?

As of Q4 2023, Terns Pharmaceuticals's earnings has grown year over year. Terns Pharmaceuticals's earnings in the past year totalled -$85.01 million.

What was TERN's revenue last quarter?

On Invalid Date, Terns Pharmaceuticals (NASDAQ: TERN) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Terns Pharmaceuticals's revenue was $0.00.

What was TERN's revenue growth in the past year?

As of Q4 2023, Terns Pharmaceuticals's revenue has grown -100% year over year. This is 212.01 percentage points lower than the US Biotechnology industry revenue growth rate of 112.01%. Terns Pharmaceuticals's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.